Thank you, GSK Canada, for visiting UAlberta and LKSIoV!

26 October 2022

GSK Canada and Dr. Tyrrell pose with a gold Nobel Prize medallion.

From left: Michelle Horn (GSK Canada Medical Director, Specialty Medicines), Lorne Tyrrell (Director, LKSIoV), Alan Oglesby (GSK Canada Director of Health Economics and Outcomes Research), Delna Sorabji (GSK Canada Medical Science Liaison Lead, Nephrology)

GlaxoSmithKline (GSK) Canada has been a long time supporter of the University of Alberta and LKSIoV, including supporting LKSIoV with $5 million in 2010, supporting a Chair in Virology, and building of laboratories such as the Glaxo CL3 (Containment Level III) lab on the 6th floor of the Heritage Medical Research Building.

We were honoured to showcase LKSIoV's work to GSK Canada as they toured the University of Alberta campus.